New cocktail of 4 drugs shows promise for tough pancreatic cancer
NCT ID NCT05984602
First seen Mar 31, 2026 · Last updated Apr 25, 2026 · Updated 5 times
Summary
This early-phase study tests a combination of two standard chemotherapy drugs plus two immune-boosting drugs in people with pancreatic cancer that can be surgically removed. The main goal is to see if the combination is safe and tolerable, and whether it helps more patients successfully undergo surgery. Only 9 participants are enrolled, and the study focuses on finding the right dose and checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ambulatory Care Center
New York, New York, 10016, United States
-
Clinical Cancer Center
New York, New York, 10016, United States
-
NYU Langone Ambulatory Care Center East 38th Street
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.